Volume: 6 Issue: 1
Year: 2018, Page: 42-45,
Introduction: Candidemia is the most common blood stream infections in neonates with high mortality and morbidity, which have increased in its incidence over the last two decades. Recent studies have detected a significant shift from Candida albicans towards non-albicans Candida (NAC) species.
Objective : The main aim of this study is to evaluate and establish this increase in incidence of candidemia in neonates mainly caused by non albicans species which has completely different spectrum of antifungal susceptibility and disease pattern.
Materials and Methods : This prospective study was conducted for a period of one year from June 2015 to May 2016. Blood samples were collected aseptically from the neonates suspected of septicaemia. Blood culture was performed by automated Bact/ Alert 3D system [Biomerieux]. The identification was based on Gram stain showing Gram positive budding yeast cells, cultural characteristics and performing Germ tube test, for preliminary speciation of candida species. All the isolates showing negative for germ tube test were presumptively put all together as Non- albicans candida.
Results : Total number of neonatal candidemia cases were 94 out of whom 66 were males and 28 were females. Number of neonates with albicans candidemia were 20 and with non albicans candidemia were 74.
Conclusion : Neonatal candidemia is a potential health problem in our tertiary care health center which mainly covers the rural population. Especially the increasing cases of non albicans candida pose a serious threat and require strict control policies and proper prophylaxis to prevent the mortality and morbidity in the nenonates and infants.
Keywords: Candidemia, neonates, gram stain, germ tube.
1. Juyal D, Sharma M, Pal S, Rathaur VK, Sharma N. Emergence of Non-Albicans Candida Species in Neonatal Candidemia. North American Journal of Medical Sciences 2013;5(9):541-545.
2. Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of North India: 5- year study. Infection 2007;35:256–9.
3. Kothari A, Sagar V. Epidemiology of Candida bloodstream infections in a tertiary care institute in India. Indian J Med Microbiol 2009;27:171–2.
4. Sardana V, Pandey A, Madan M, Goel SP, Asthana AK. Neonatal candidemia: A changing trend. Indian J Pathol Microbiol 2012;55:132–3.
5. Rowen JL, Tate JM, Nordoff N, et al. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J Clin Microbiol 1999;37:3735– 3737.
6. Linder N, Klinger G, Shalit I, et al. Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations. J Antimicrob Chemother 2003;52:663–667.
7. Cohen-Wolkowiez M, Benjamin DK, Smith PB. Management of Neonatal Candidiasis. The Pediatric infectious disease journal 1998;17(11):1007-1011.
8. Wadile RG, Bhate VM. Study of clinical spectrum and risk factors of neonatal candidemia. Indian J Pathol Microbiol 2015; 58(4): P 472-474.
9. Kv cmery V, Barnes AJ. Non albicans candida species causing fungemia: Pathogenicity and antifunagal resistance. J Hosp Infect 2002; 50 (4): P 243-260.
10. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version. www.OpenEpi.com, updated 2013/04/06, accessed 2015/ 05/20.
11. Pammi M, Holland L, Butler G, Gacser A, Bliss JM. Candida parapsilosis is a Significant Neonatal Pathogen: A Systematic Review and Meta-Analysis. The Pediatric infectious disease journal 2013;32(5):e206-e216.
Ritu Vaish. Evaluation of neonatal candidemia: Emergence of non- albicans candida. Perspectives in Medical Research 2018;6(1):42-45.